Prediction of early response to liraglutide therapy in patients with obesity
BACKGROUND: The main goal of treating obesity is to reduce the risk of developing its complications and comorbid diseases, which requires a steady decrease in body weight by at least 510%. In Russia in 2016, the list of drugs for the treatment of obesity was supplemented by a glucagon-like peptide 1...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2020-06-01
|
| Series: | Ожирение и метаболизм |
| Subjects: | |
| Online Access: | https://omet-endojournals.ru/omet/article/viewFile/12274/9554 |